Skip to navigationSkip to main contentSkip to right columnADVERTISEMENTFatima GulzarSat, June 27, 2026 at 5:32 PM GMT+2 1 min readAbbott Laboratories (NYSE:ABT) is among the Best Brain-Computer Interface Stocks.On June 4, Reuters reported a federal judge ruled that Abbott Laboratories (NYSE:ABT) must face a proposed class-action lawsuit alleging it misled consumers by marketing PediaSure Grow & Gain drinks as "clinically proven" to help children grow.US District Judge Paul Engelmayer said labeling featuring a giraffe and ruler-like marks could lead consumers to interpret "grow" as height gain, while "gain" implied weight. Hence, the claims will proceed, and Abbott Laboratories (NYSE:ABT) must defend.In a 75-page decision, Engelmayer noted jurors could find the firm's commercials reinforced that message, citing an ad showing a boy comparing himself to taller peers.Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children's GrowthThe corporation said its labeling is "appropriate" and backed by evidence, maintaining PediaSure supports children's growth and development.Plaintiff Joanne Noriega said her grandson remained short after a year of daily use but became overweight, while her lawyer James Denlea said he welcomed the ruling.Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare products. It operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices segments.While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.Disclosure: None. Follow Insider Monkey on Google News.Terms and Privacy PolicyEU DSA contactPrivacy & Cookie SettingsMore Info